Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): The ODIXa-DVT (oral direct factor Xa inhibitor BAY 59-7939 in patients with acute symptomatic deep-vein thrombosis) study
Date
2007Author
Goldhaber, Samuel Z
Haas, Sylvia
Huisman, Menno V
Hull, Russel D
Kakkar, Ajay K
Misselwitz, Frank
Schellong, Sebastian
Agnelli, Giancarlo
Gallus, Alexander Stephen